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Bovine respiratory disease is a complex of bacterial and viral infections of economic and welfare importance to the
beef industry. Although tracheal antimicrobial peptide (TAP) has microbicidal activity against bacterial pathogens
causing bovine respiratory disease, risk factors for bovine respiratory disease including BVDV and stress
(glucocorticoids) have been shown to inhibit the induced expression of this gene. Lipopolysaccharide is known to
stimulate TAP gene expression, but the maximum effect is only observed after 16 h of stimulation. The present
study investigated other agonists of TAP gene expression in primary cultures of bovine tracheal epithelial cells.
PCR analysis of unstimulated tracheal epithelial cells, tracheal tissue and lung tissue each showed mRNA expression
for Toll-like receptors (TLRs) 1–10. Quantitative RT-PCR analysis showed that Pam3CSK4 (an agonist of TLR1/2)
and interleukin (IL)-17A significantly induced TAP gene expression in tracheal epithelial cells after only 4–8 h of
stimulation. Flagellin (a TLR5 agonist), lipopolysaccharide and interferon-α also had stimulatory effects, but little or
no response was found with class B CpG ODN 2007 (TLR9 agonist) or lipoteichoic acid (TLR2 agonist). The use of
combined agonists had little or no enhancing effect above that of single agonists. Thus, Pam3CSK4, IL-17A and
lipopolysaccharide rapidly and significantly induce TAP gene expression, suggesting that these stimulatory pathways
may be of value for enhancing innate immunity in feedlot cattle at times of susceptibility to disease.Introduction
Tracheal antimicrobial peptide is an inducible β-defensin
that is highly expressed in the bovine respiratory tract and
has demonstrated antimicrobial effects on pathogens
that cause bovine respiratory disease, including Man-
nheimia haemolytica, Histophilus somni and Pasteurella
multocida [1-3]. TAP expression is induced by several
pro-inflammatory cytokines as well as bacterial compo-
nents such as lipopolysaccharide (LPS) [4-7]. However,
infection with certain viruses and bacteria, or exposure
to glucocorticoids, inhibits this response to LPS, imply-
ing that this may be one mechanism by which stress and
viral infection increase the risk of bacterial pneumonia
in cattle [8-11]. Importantly, the susceptibility of bovine
bacterial pathogens to TAP suggests that restoring this* Correspondence: jcaswell@uoguelph.ca
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unless otherwise stated.suppressed response may be a viable method to prevent
disease in stressed or virus-infected cattle [11].
The induction of TAP gene expression by LPS is delayed
and does not reach zenith until 16 h of stimulation, per-
haps suggesting indirect signal transduction. Thus, the
purpose of this study was to determine which TLR recep-
tors are constitutively expressed by bovine tracheal epithe-
lial cells, and to identify agonists that induce high levels of
TAP gene expression more rapidly than LPS. Toll-like re-
ceptor (TLR) ligands were a focus of the study, including
lipoteichoic acid (TLR2/2), Pam3CSK4 (TLR2/1), FSL-1
(TLR2/6), LPS (TLR4), flagellin (TLR5), and CpG ODN
2007 (TLR9). We also examined IL-17A because of its
emerging recognition as a critical stimulus for mucosal
defence against bacterial infection, and interferon (IFN)-α
because of the commercial availability of an immunosti-
mulant (inactivated Parapoxvirus ovis, Zylexis) known to
induce its expression [12].al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Toll-like receptor and IL-17A receptor subunit A gene
expression
Tracheal and lung tissue from three clinically and patho-
logically normal market-weight calves were obtained at
the time of slaughter. From each calf, 30 mg samples of
tracheal mucosal tissue and lung tissue were washed in
PBS and preserved in RNAlater® at 4 °C for 24 h prior to
storage at −80 °C. Adjacent samples of the same tissues
were fixed in formalin for 48 h and histologic sections
were prepared routinely. Histologically, the tracheal and
lung samples from all calves were within normal limits
and had only low numbers of lymphocytes, plasma cells,
and few neutrophils.
Fresh tracheas were obtained as above and primary
cultures of bovine tracheal epithelial cells (bTEC) were
prepared as previously described [10]. Briefly, cells were
cultured for 4–6 days until 80-90% confluency in a 1:1
mixture of Dulbecco’s modified Eagle’s medium and
Ham’s F-12 medium containing 10% fetal bovine serum,
0.1 mg/mL penicillin-streptomycin, 5 μg/mL amphoteri-
cin B, 0.5 mg/mL cell culture grade gentamycin, 25 μg/
mL bovine pituitary extract, 25 ng/mL epidermal growth
factor and 1% insulin-transferrin-selenium. To confirm
the epithelial nature of the cells, immunohistochemistry
was performed on cells fixed in 70% ethanol and sus-
pended in HistoGel™ (Thermo Fisher Scientific Inc.) for
pancytokeratin (AE1/AE3, M3515, Dako, ON, Canada)
and vimentin (M0725, Dako); negative control sections
were processed in the same way with omission of the pri-
mary antibody. RNA was extracted from tissues preserved
in RNA later® and from cultured bTEC using RNAeasy®
Mini Kit capture columns (QIAGEN Inc, Mississauga,
ON, Canada) and QIAshredder™ (QIAGEN Inc) according
to manufacturer’s instructions. Genomic DNA was re-
moved by treatment with DNase I (QIAGEN Inc). The
concentration and quality of extracted RNA was measured
using a Nanodrop 2000 spectrophotometer (Thermo
Scientific; Wilmington, DE, USA). Complementary single-
stranded DNA (cDNA) was reverse transcribed from
100 ng total RNA using Super Script® III reverse tran-
scriptase (Thermo Scientific) according to the manufac-
turer’s protocol using oligo dTs as the primer. Once
cDNA synthesis was completed, samples were incubated
at 37 °C for 20 min with ribonuclease H (Invitrogen) to re-
move any remaining RNA.
PCR amplification of cDNA was completed using
primers for TLRs 1–10 [13,14]. For IL-17RA, sequences
were obtained from NCBI (XM_002683626.2) and primers
were designed using NCBI primer designer software: for-
ward primer 5’-GTGCCCGACTGCAAGGACCC-3’, re-
verse 5’-CTGGGTGGCTTCCTGTGCGG-3’, 250 bp
product size. The PCR profile was as follows: 95 °C for
5 min, 95 °C for 30 s, 58 °C for 30 s for TLR primersand 65 °C for 30 s for IL-17RA primers, 72 °C for 30 s,
repeat from step 2 for 35 cycles, 72 °C for 5 min. The
PCR products were analyzed by gel electrophoresis
using 0.01% SYBR® Safe gel dye on a 5% agarose gel
(Sigma, St. Louis, MO, USA) in 0.5× Tris/Borate/EDTA
buffer (Sigma). Product sizes were compared to a 100 bp
ladder, and products of each reaction were confirmed once
by sequencing. Pooled cDNA from mesenteric lymph node
and ileum obtained from a healthy Holstein calf were used
as positive controls for the TLR gene expression study, be-
cause these tissues were previously shown to express all 10
bovine TLRs [13]. Negative controls consisted of PCR reac-
tions that included receptor-specific primer pairs but con-
tained no template cDNA.
Effect of agonists on TAP gene expression
Confluent bTEC, cultured as described above, were incu-
bated with serum-free medium (DMEM/F12, 0.1 mg/mL
penicillin-streptomycin and 1.5 μg/mL amphotericin B)
at 37 °C in 5% CO2 for 6–12 h, then incubated in tripli-
cate with various TLR agonists or cytokines. The effect
of different doses of each agonist was examined first,
with subsequent testing of the time course needed to in-
duce gene expression at the optimal doses. The TLR ago-
nists included lipoteichoic acid from Staphylococcus
aureus (an agonist of TLR2/2 homodimer; Sigma-Aldrich,
St. Louis, MO, USA, item number L2630), Pam3CSK4
(agonist of TLR2/1 heterodimer; Invivogen, San Diego,
CA, item t1rl-pms), FSL-1 (agonist of TLR2/6 heterodi-
mer; Invivogen, item t1r1-fsl), flagellin from Salmonella
enteritica serovar Typhimurium (TLR5 agonist; Invivogen,
San Diego, CA, item t1r1-pstfla), and class B CpG ODN
2007 (bovine/porcine-specific TLR9 agonist; Invivogen,
item t1rl-2007) along with the negative control of non-
CpG ODN 2007 (consisting of GpC motifs; Invivogen,
item t1r1-2007c). The cytokines included bovine recom-
binant IL-17A (Kingfisher Biotech, St. Paul, MN, USA,
item number RP0056B-005) and bovine recombinant
IFN-α (Kingfisher Biotech, item RP0008B-025). Lipopoly-
saccharide derived from Pseudomonas aeruginosa (TLR4
agonist; Sigma Aldrich, MO, USA, item L9143), was in-
cluded as a standard and positive control in each trial, at a
concentration of 0.1 μg/mL that had been previously
optimized [10].
To quantify relative gene expression, real-time reverse
transcription quantitative PCR was conducted using Light-
Cycler® 480 technology (Roche Diagnostics, Mannheim,
Germany). Constant amounts of cDNA synthesized from
100 ng of total RNA were used in each reaction to measure
gene expression of TAP relative to the reference gene
glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The
GAPDH Ct values remained within 1 threshold cycle across
various treatments, confirming constant gene expression
under the conditions tested. The primer sequences and
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forward 5’-TCTTCCTGGTCTGTCTGCT-3’, reverse 5’-
GCTGTGTCTTGGCCTTCTTT-3’, 183 bp product size;
GAPDH forward 5’-GGCGTGAACCACG AGAAGTAT
AA-3’, reverse 5’-CCCTCCACGATGCCAAAGT-3’, 120 bp
product size [10]. Amplification efficiencies of 1.91 for
TAP and 1.88 for GAP were determined from the
slope of a standard curve constructed from a series of
1:5 serial dilutions of cDNA synthesized from LPS-
stimulated bTEC. A middle dilution was used in each
qPCR run as a calibrator to control for plate-to-plate
variation. Each qPCR reaction consisted of 10 μL of
2× LightCycler®480 SYBR Green 1 master mix (Roche
Diagnostics, Mannheim, Germany), 0.5 μL each of
forward and reverse primers (10 μM), 7 μL of PCR
grade water and 2 μL of 1:10 diluted template cDNA.
The reaction was started by a pre-incubation step at
95 °C for 7 min followed by 45 amplification cycles
consisting of 95 °C for 15 s, 63 °C for 15 s, and 72 °C
for 20 s. Once completed, a melting curve was pro-
duced at 95 °C for 5 s then 45 °C for 1 min. The reac-
tion was concluded by a cooling step at 40 °C for 1 min.
The samples were run in technical duplicates for both
the gene of interest (TAP) and the reference gene
(GAPDH) then averaged for advanced relative quantifi-
cation analysis using LightCycler®480 software (Roche
Diagnostics, Mannheim, Germany). Two types of nega-
tive controls were used in each trial: a non-stimulation
control that differed from the other wells only in the ab-
sence of an agonist, and an additional negative control
containing master mix but no template cDNA.Statistical analysis
A general linear mixed model was used to fit the
normalized ratios using Proc MIXED (SAS 9.2). Fixed
effects were a combination of agonist and dose by
time and the combination by time interaction were
also included in the model. Calf identification was a
random blocking variable (a random effect), and the
random interaction of calf identification by dose-
agonist combination by time was used to handle sub-
sampling (biologic triplicates). To assess the ANOVA
assumptions, residual analyses were conducted. The
residuals were formally tested for normality using the
four tests offered by SAS (Shapiro-Wilk, Cramér-von
Mises, Kolmogorov-Smirnov and Anderson-Darling
tests). In addition, the residuals were plotted against
the predicted values and explanatory variables in-
cluded in the model. Log transformation and exclu-
sion of 2 outliers produced a fundamentally normal
distribution of data. P < 0.05 was considered signifi-
cant. The data are shown graphically as mean ±
standard error of the mean (SEM).Results
Toll-like receptor and IL-17A receptor subunit A gene
expression in bovine respiratory cells and tissue
Using immunohistochemistry, primary cultures of bTEC
had positive cytoplasmic labeling for pancytokeratin and
about 5% had positive cytoplasmic labeling for vimentin
(Figure 1). The negative control, prepared by omitting
the primary antibody, did not show background staining.
Unstimulated bTEC, tracheal tissue, lung tissue, and the
positive control (pooled RNA from mesenteric lymph
node and ileum) each expressed mRNA for all 10 bovine
TLRs examined (Figure 2). Findings in cell cultures, tra-
cheal tissue, and lung tissue were similar for all 3 calves
examined. The bTEC and the positive control each
showed mRNA expression of IL-17RA (data not shown).
Effect of agonists on TAP gene expression
TAP gene expression was measured in bTEC stimulated
with TLR agonists and cytokines. Pam3CSK4, an agonist
of the TLR2/1 heterodimer, induced TAP gene expression
in a dose-dependent manner from 31.6 ng/mL to a max-
imal effect at the highest dose tested of 3.16 μg/mL. This
effect was significantly different from the non-stimulated
control and from LPS-stimulated cells (Figure 3A). At this
dose, the magnitude of effect was significantly greater
than induction by LPS. The findings were similar in
both calves tested, although the magnitude of the re-
sponse differed. Induction of TAP gene expression was
detected as early as 4 h with 1 μg/mL Pam3CSK4 stimu-
lation (Figure 3B).
FSL-1, a TLR2/6 agonist, also showed significant in-
duction of TAP gene expression. A dose of 31.6 ng/mL
induced the highest levels of TAP gene expression
(Figure 3C). Using this concentration in the time course
study, FSL-1 induced significantly greater TAP gene ex-
pression compared to the negative control and LPS as
early as 4 h of stimulation (Figure 3D). In contrast, lipo-
teichoic acid, an agonist of the TLR2/2 homodimer, did
not significantly induce TAP gene expression in doses
ranging from 10–1000 ng/mL (Figure 3E), although the
bTEC used in this experiment did respond as expected
to LPS (confirming the viability and responsiveness of
these cells). In an earlier time-course study using a lipo-
teichoic acid dose of 20 μg/mL and bTEC sourced from
a different calf, significant induction of TAP gene ex-
pression was found at 8 and 16 h, albeit at much lower
magnitude than for stimulation with LPS (Figure 3F).
In bTEC stimulated with flagellin, a TLR5 agonist, a
dose of 316 ng/mL (the highest dose tested) significantly
induced TAP gene expression compared to the non-
stimulated control. This effect was dose-dependent at
both 8 and 16 h of stimulation (Figure 3G). Using this
dose, significant induction of TAP gene expression was
first detected at 8 h of stimulation (Figure 3F). However,
Figure 1 Histologic appearance of trypsinized primary cell cultures of bovine tracheal epithelial cells. A) Hematoxylin and eosin stain.
B) Immunohistochemistry for pancytokeratin. C) Immunohistochemistry for vimentin, with immunolabeled cells shown by arrows.
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sion than LPS at any of the doses or times tested.
Stimulation of bTEC with various doses of CpG ODN
2007 (a bovine/porcine TLR9 agonist) and its non-CpG
control did not induce significant TAP gene expression
at 8 or 16 h (Figure 4A). A minor non-significant increase
was noted for both CpG ODN 2007 and the non-CpG
control in the time course study, and a similar non-
significant trend was found in the dose–response study.
However, CpG did not induce gene expression signifi-
cantly higher than its non-CPG control at any time
(Figure 4B).
Stimulation of bTEC with recombinant bovine IL-17A
showed dose-dependent induction of TAP gene expres-
sion, to a maximum of 316 ng/mL (the highest dose
tested) (Figure 4C). At this dose, IL-17A significantly in-
duced TAP expression after 8 h of stimulation, with a
non-significant increase in TAP gene expression as early
as 4 h (Figure 4D).
Stimulation of bTEC with recombinant bovine IFN-α
showed that a dose of 1000 ng/mL (the highest dose
tested) significantly induced TAP gene expression in com-
parison to the non-stimulated control (Figure 4E). UsingFigure 2 Expression of Toll-like receptor (TLR) in tracheal
epithelial cells, tracheal mucosa, and lung. Basal expression of
mRNA expression for TLRs 1–10 was evaluated in cultured bovine
tracheal epithelial cells, tracheal mucosal tissue, lung tissue, and
positive control tissue (pooled mesenteric lymph node and ileum).
Lanes 1–10: Samples of extracted RNA were reverse transcribed then
amplified by PCR using specific primers, and the product was
examined on an agarose gel. The gel lanes match the
corresponding TLR (eg. the lane labelled 1 is TLR1), and the data
shown from 1 calf are representative of the 3 calves examined.
L: DNA molecular size standards: 400, 300, 200 and 100 bp.this dose of IFN-α, significant induction of TAP gene ex-
pression occurred after 4 h of stimulation and remained
significantly elevated at later time points. Even though
there was a rapid induction caused by IFN-α, it was not
higher than LPS (Figure 4F).
A summative experiment was conducted to compare
the effects of Pam3CSK4, IL-17A and LPS on induction
of TAP gene expression in bTEC from 4 calves (Figure 5).
As above, all agonists had significantly greater effects
than no stimulation. Pam3CSK4 induced significantly
higher TAP gene expression than did IL-17A or LPS, at
both 8 and 16 h of stimulation for all 4 calves examined.
IL-17A also induced significantly higher gene expression
than LPS after 8 h, but not at 16 h. Differences among
the 4 animals tested were significant (P < 0.0001).
Three experiments (conducted on different days using
cells from different calves) examined the combined ef-
fects of LPS, Pam3CSK4 and IL-17A on TAP gene ex-
pression (Figure 6). All combinations of agonists tested
had a greater effect than IL-17A alone (1-way ANOVA,
P < 0.05). In one experiment, the combination of LPS
and IL-17A had a greater effect than any single agonist
(Figure 6A), but the difference was small and not found
in the second experiment (Figure 6B). Other combina-
tions of agonists did not have significantly different ef-
fects than that of Pam3CSK4 alone or of LPS alone.
Discussion
The present study investigated factors that induce anti-
microbial peptide gene expression in bovine tracheal epi-
thelial cells, with the intent of developing methods to
stimulate this response to prevent respiratory disease.
The morphology and cytokeratin expression of the pri-
mary cell cultures confirmed an epithelial phenotype;
occasional cells co-expressed cytokeratin and vimentin,
which was consistent with prior reports of tracheobron-
chial epithelial cells [15]. Initial findings identified gene
expression of TLRs 1–10 as well as IL-17RA in bTEC as
well as in tracheal and lung tissue, consistent with other
findings using primary cultured airway epithelial cells
[16]. Histologically, tracheal and lung samples from all
calves contained lymphocytes, plasma cells, and neutro-
phils, albeit in low number. This study examined the
Figure 3 Effects of Pam3CSK4, FSL-1, lipoteichoic acid and flagellin on tracheal antimicrobial peptide gene expression. Dose- and
time-dependent effects were measured for Pam3CSK4 (A,B), a TLR2/1 agonist; FSL-1 (C,D), a TLR2/6 agonist; lipoteichoic acid (LTA) (E,F), a TLR2/2
agonist); and flagellin (G,H), a TLR5 agonist. For the dose–response studies (A,C,E,G), confluent bTEC were stimulated in triplicate with various
concentrations of agonist for 16 h. For the time-course studies (B,D,F,H), confluent bTEC were stimulated in triplicate for 4, 8, 16 or 24 h with the
doses of agonist shown. Gene expression of TAP relative to that of GAPDH was measured using real-time RT-qPCR. Lipopolysaccharide (LPS,
0.1 μg/mL) was used in all assays as a positive control and standard. *, significantly different from unstimulated cells (P < 0.05).
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is acknowledged that post-translational regulation of these
expressed genes would determine functional activity of
these cell-surface receptors. However, the subsequent find-
ing that agonists of these receptors induced TAP gene ex-
pression implies that functional receptors were expressed.
As a result of these findings, agonists for TLRs 1, 2, 5, 6
and 9 and IL-17RA were studied to determine their effect
on induction of TAP gene expression.
TLR2 functions either as a homodimer or as heterodi-
mers with TLRs 1 or 6. TLR 2/2 recognizes cell wall
components of Gram-positive bacteria such as peptido-
glycan and lipoteichoic acid; the TLR 2/2 agonist lipotei-
choic acid is a lipid bound to a glycerol phosphate chain.TLR 2/1 recognizes triacylated lipopeptides found in the
membrane of Gram-positive and Gram-negative bacteria;
Pam3CSK4, a synthetic tripalmitoylated lipopeptide re-
sembling the acylated terminus of bacterial lipoproteins, is
an agonist of TLR 2/1. TLR 2/6 recognizes bacterial li-
poproteins including FSL-1, an N-terminal fragment of
the diacylated LP44 lipoprotein of Mycoplasma salivar-
ium [17,18].
Pam3CSK4, the TLR 2/1 agonist, significantly induced
TAP gene expression in comparison to non-stimulated
controls and to LPS, and this stimulatory effect was ob-
served in a dose- and time-dependent manner. These re-
sults are consistent with studies in humans that have
shown up-regulation of human β-defensin-2 (hBD-2)—
Figure 4 Effects of CpG oligodinucleotide, interleukin-17A and interferon-α on tracheal antimicrobial peptide gene expression.
Dose- and time-dependent effects were measured for CpG oligodinucleotide (A,B), a TLR9 agonist; interleukin-17A (C,D); and interferon-α (E,F).
For the dose–response studies (A,C,E), confluent bTEC were stimulated in triplicate with various concentrations of agonist for 16 h. For the
time-course studies (B,D,F), confluent bTEC were stimulated in triplicate for 4, 8, 16 or 24 h with the doses of agonist shown. Gene expression of
TAP relative to that of GAPDH was measured using real-time RT-qPCR. Lipopolysaccharide (LPS, 0.1 μg/mL) was used in all assays as a positive
control and standard. *, significantly different from unstimulated cells (P < 0.05).
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airway epithelial cells [19]. Stimulation of human tra-
cheobronchial epithelial cells with Pam3CSK4 induced
antimicrobial activity against both Gram-positive and
Gram-negative bacteria including Pseudomonas aerugi-
nosa and Listeria monocytogenes [19]. The rapid effect
suggests that Pam3CSK4 interacts with TLR 2/1 on the
cell surface to trigger intracellular signalling that directly
activates transcription of β-defensin genes.
As for Pam3CSK4, stimulation of bTEC with the TLR
2/6 agonist FSL-1 resulted in robust induction of TAP
gene expression, in comparison to a non-stimulated con-
trol or LPS. In contrast, lipoteichoic acid, the TLR 2/2
agonist, did not induce greater TAP gene expression in
the dose–response study than for LPS, and only pro-
duced a minimal induction during the time course study.
In previous studies, LTA significantly upregulated gene
expression of both TAP and lingual antimicrobial peptide
in primary bovine mammary epithelial cells. However,
when compared to LPS, the effect of LTA in stimulating
β-defensin as well as pro-inflammatory cytokine gene ex-
pression was significantly lower [5]. Similarly, in a studyusing human lung epithelial cells, stimulation with LTA
showed lower induction of IL-8 gene expression com-
pared to stimulation with LPS [16,20]. Thus, the findings
suggest that heterodimerization of TLR2 with TLR1 or
TLR6 may augment its function in stimulating this innate
immune response.
Flagellin, the major protein of flagella of Gram-negative
and Gram-positive bacteria, activates TLR5. In this study,
flagellin induced TAP gene expression in bTEC in a dose-
and time-dependent fashion. However, it never produced
effects as high as or earlier than those induced by LPS.
With regards to the in vivo relevance, the major Pas-
teurellaceae bacterial pathogens causing bovine respira-
tory disease do not possess flagella, suggesting that
TLR5 stimulation is not important in pathogenesis of
this disease.
Bacterial DNA contains 20 times more unmethylated
CG dinucleotides than mammalian DNA, and these
CpG motifs are immunostimulatory and recognized by
mammalian TLR9 [21,22]. This study used CpG ODN
2007, a bovine/porcine-specific class B ODN, which had
no significant effect on TAP gene expression compared
Figure 5 Comparison of the effects of IL-17A, Pam3CSK4 and
LPS on tracheal antimicrobial peptide gene expression.
Confluent cultures of tracheal epithelial cells from 4 different calves
were non-stimulated (NS) or stimulated with 1 μg/mL Pam3CSK4,
316 ng/mL IL-17A, or 0.1 μg/mL LPS for 8 h (A) and 16 h (B) in
triplicate. Gene expression was assessed using real-time RT-qPCR.
Pam3CSK4 induced significantly higher tracheal antimicrobial
peptide gene expression than IL-17A and LPS at both 8 and 16 h
(P < 0.05). IL-17A induced significantly higher gene expression than
LPS at 8 h (P < 0.05).
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other studies that have shown that CpG ODN had no ef-
fect on pro-inflammatory cytokine production in human
bronchial epithelial cells [23], although another study
found that microbial DNA induced gene expression ofFigure 6 Effect of stimulation with single agonists compared to comb
stimulated for 16 h in triplicate with various combinations of 1 μg/mL Pam
peptide gene expression was measured as above. The effects of combined
minimally or not different than that of lipopolysaccharide (LPS) or Pam3CS
conducted on different days using cells from different calves.hBD-2 in airway epithelial cells by interaction with TLR9
and through activation of NF-κB [24]. CpG may need to
be combined with other inflammatory cytokines in order
to induce an innate response in epithelial cells; for ex-
ample, CpG augmented IL-8 production in bronchial epi-
thelial cells co-stimulated with IL-1β and tumour necrosis
factor-α, and co-stimulation of mice with class C CpG-
ODN2395 and Pam2CSK4 had greater resistance to bac-
terial challenge than either agonist alone [25-27]. Finally,
it is noted that other classes of CpG ODNs were not
tested in the present study and may have differing effects.
IL-17A is a potent pro-inflammatory and immunosti-
mulatory cytokine produced by T helper 17 lymphocytes,
type 3 innate lymphoid cells and bovine γδ-T cells [28,29].
IL-17 is important for defence of the respiratory tract
against bacterial pathogens including Staphylococcus aur-
eus, Pseudomonas aeruginosa and Legionella pneumophila
infections in mice [30-32]. In the present study, IL-17A
receptor subunit A gene expression was identified in
bTEC, consistent with prior findings in human airway
epithelial cells [33]. Exposure of these cells to IL-17A
stimulated TAP gene expression in bTEC in a dose- and
time-dependent fashion, to a greater degree than did
stimulation with LPS. This result is consistent with
studies of IL-17A inducing human β-defensin-2 expres-
sion in human airway epithelial cells and TAP in bovine
mammary epithelial cells [33,34]. These findings suggest
that IL-17A induces innate mucosal antimicrobial de-
fences in the bovine respiratory tract.
IFN-α is an antiviral type I interferon. The presence of
viral or bacterial nucleic acid within cells stimulates
pattern recognition receptors including NOD-like recep-
tors, RIG-I-like receptors, and TLRs 3, 4, 7, 8 and 9,
activating interferon regulatory factors to induce IFN-α
expression [35]. Secreted IFN-α then interacts with the
IFNαβ receptor (IFNAR1/2) to activate the JAK/STAT
signalling pathway and induce expression of over 300
immune response genes [36]. IFNAR is expressed in allined agonists. Cultured bovine tracheal epithelial cells were
3CSK4, 316 ng/mL IL-17A, or 0.1 μg/mL LPS. Tracheal antimicrobial
agonists were greater than that of interleukin-17A (IL-17A) alone, but
K4 alone. The data shown (panels A, B and C) represent 3 studies
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present study, IFN-α induced TAP gene expression in
bTEC only at the highest dose tested and not consist-
ently greater than LPS, although there was significant in-
duction of TAP gene expression as early as 4 h.
Significant differences in agonist-induced TAP gene
expression were identified when tracheal epithelial cells
from different animals were tested in the same experi-
ment. Similarly, replication of experimental findings using
tracheal epithelial cells from a different animal yielded
qualitatively similar but quantitatively different results.
These findings suggest differences among animals in the
magnitude of response to the various agonists. Thus, com-
parison between agonists is only valid for those experi-
ments in which different agonists were compared in the
same experiment.
Caution is warranted because in vitro nature of this
study would not address the complex interactions be-
tween different cell types that occur in the respiratory
tract. However, this is advantageous because it allows a
specific focus on epithelial cell responses. Further, it is
possible that the surface mucus layer present in vivo might
alter the effect of agonists, and this in vitro work avoids
this complication. Finally, additional studies are needed to
determine whether in vivo stimulation of this immunoin-
flammatory response would protect calves against pneu-
monia or increase the risk of disease due to a heightened
response to bacteria.
The findings of this study are important for under-
standing host responses to pathogens and for develop-
ment of methods to stimulate innate immune responses
in cattle. Tracheal epithelium is a dynamic sensor of
threats entering into the lung and responds to pathogens
by providing a physical barrier, a mucociliary escalator,
and by secreting various antimicrobial peptides, immu-
nunomodulatory proteins, antioxidants and chemokines
that attract other cells of both the innate and adaptive
immune responses. Tracheal antimicrobial peptide is se-
creted from the respiratory epithelium in an inducible
manner and has bactericidal activity against the major
pathogens that cause pneumonia in cattle [1]. Other func-
tions include antiviral effects, CCR6-dependent chemo-
taxis of immature dendritic cells and T lymphocytes, and
epithelial cell proliferation and wound repair [38]. Prior
studies have shown that LPS induces TAP gene expres-
sion, but the present findings indicate more rapid effects
by stimulation of TLR2 and IL-17RA pathways. Although
previous studies have shown that using combinations of
agonists produced synergistic induction of β-defensins in
airway epithelium [34,39,40], the use of combined agonists
had minimal or no synergistic effect in this study. Further,
combined stimulation may increase the risks of adverse
effects, so identifying specific effective pathways is import-
ant and therefore was the focus of this work. TAP hasantimicrobial activity against the pathogens that cause
pneumonia in cattle, but induction of TAP gene expres-
sion in bTEC is blocked by stress (modeled by glucocorti-
coids) or bovine viral diarrhea virus infection. The present
study suggests that TLR2 agonists or IL-17A may be of
value to stimulate this aspect of innate immunity in im-
munosuppressed feedlot cattle.
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